Company profile: Affymetrix
1.1 - Company Overview
Company description
- Provider of innovative technologies enabling multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating rapid translation of results into biology. Offerings include GeneChip microarrays for gene expression and genetic variation analysis, GeneTitan for high-throughput microarray processing, Axiom genotyping solutions, and CytoScan cytogenetic microarrays for detecting chromosomal abnormalities.
Products and services
- Axiom: A genome-wide genotyping product that delivers comprehensive coverage for association studies and other genetic research
- CytoScan: Affymetrix engineers a cytogenetic microarray platform for detecting chromosomal abnormalities in clinical and research settings
- GeneChip: A microarray-based product enabling multiplex and parallel analysis of gene expression and genetic variations in biological samples.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Affymetrix
Twelve Bio
HQ: Denmark
Website
- Description: Provider of CRISPR-Cas12a-based diagnostic technology for detecting and editing DNA sequences, leveraging an RNA-protein molecule where RNA identifies specific DNA targets and the protein acts as a biological scissor to cut and modify them.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Twelve Bio company profile →
LevitasBio
HQ: United States
Website
- Description: Provider of label-free cellular analysis, isolation, and enrichment solutions using magnetic levitation. Offers LeviCell EOS (simultaneous processing of up to four samples) and LeviCell 1.0 for non-damaging examination and delivery of biological signatures, LeviSelect kits for lysis-free RBC and CD45+ depletion, and LeviMetrics AI software for sample characterization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LevitasBio company profile →
Sloning Biotechnology
HQ: Germany
Website
- Description: Provider of tailored protein engineering solutions for industrial and biopharmaceutical sectors, leveraging the patented Slonomics technology platform to build DNA molecules with exceptional features regarding sequence limitations, reliability, and production cost on an industrial-scale robotic system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sloning Biotechnology company profile →
Evitria
HQ: Switzerland
Website
- Description: Provider of global antibody expression services specialized in CHO-based transient production of recombinant antibodies, including chimeric, bispecific, Fc-optimized, fusion, afucosylated (GlymaxX) and Fc-silenced (STR) variants. Offers bispecific formats (Duobody, IgG-scFvs, Knobs-into-Holes) and transient expression of secreted proteins (scFvs, extracellular domains, cytokines, viral proteins).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evitria company profile →
Axion Biosystems
HQ: United States
Website
- Description: Provider of multi-electrode array and impedance-based platforms for real-time, continuous, label-free cellular analysis, including monitoring of proliferation, viability, morphology, attachment, signaling, and immune cell-mediated killing. Offers single- and multi-well systems, high-throughput formats, automation modules, and integrated circuits to eliminate stimulation artifacts for research, clinical, and drug discovery markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axion Biosystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Affymetrix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Affymetrix
2.2 - Growth funds investing in similar companies to Affymetrix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Affymetrix
4.2 - Public trading comparable groups for Affymetrix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →